The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. - Wikidata - awgldk - TriplyDB

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.

http://www.wikidata.org/entity/Q37677911

about

Cellular treatments for spinal cord injury: the time is right for clinical trials Potential role of stem cells in severe spinal cord injury: current perspectives and clinical data Mesenchymal stem cell transplantation in multiple sclerosis Conditioned medium of human adipose-derived mesenchymal stem cells mediates protection in neurons following glutamate excitotoxicity by regulating energy metabolism and GAP-43 expression Dual Inhibition of Activin/Nodal/TGF-β and BMP Signaling Pathways by SB431542 and Dorsomorphin Induces Neuronal Differentiation of Human Adipose Derived Stem Cells.Using existing data to identify candidate items for a health state classification system in multiple sclerosis.Combination of electroacupuncture and grafted mesenchymal stem cells overexpressing TrkC improves remyelination and function in demyelinated spinal cord of rats.The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis.Are nestin-positive mesenchymal stromal cells a better source of cells for CNS repair?How stem cells speak with host immune cells in inflammatory brain diseases Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation.Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE)Mesenchymal stem cells in multiple sclerosis - translation to clinical trials Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis.Mesenchymal properties of SJL mice-stem cells and their efficacy as autologous therapy in a relapsing-remitting multiple sclerosis model.Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.Current stem cell treatments for spinal cord injury The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus.Therapeutic potential of mesenchymal stem cells in regenerative medicine Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy.Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model.Multiple Sclerosis International Federation: stimulating international cooperation in research Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism.Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.

P2860

Q24630772-6BCBF4B4-2AA1-4258-A8AF-25BF0FA2372E Q26996685-1AF7812E-166D-4E0A-82B3-1C3E7401D03C Q26999783-DA881CCB-B940-4D47-BB3B-410C222CF530 Q28396387-4ABE8EDD-37F5-4666-8139-AE53F8644C66 Q30277695-1CA44B6E-C5FB-4620-B93E-490595DAB1CE Q30715052-C5951767-D76F-4072-A868-D6A5AAFE72BC Q33562398-7778E0E5-2393-41BD-970E-03F244486102 Q33577019-600A2C8D-94AD-4685-AF88-DB377DEBE0C0 Q33757255-A25BD4FE-8C12-4685-ACB9-B069482E24A2 Q33776557-30EBB3BD-D6FB-4923-A31E-B8E8B065CDB8 Q34120467-CD14D6BD-40D1-4D80-915E-AD8616D6DE5B Q34168051-92B7839E-82EB-44C7-A4AC-CFE6729D02F9 Q34240433-2D6452DC-D88B-4FED-9AB5-09FD47269880 Q34564111-9FD70FFB-92CC-40A5-86F2-F7EE4FA8BB2A Q34595662-E45ED850-F0EB-4EED-A6D4-ECD646512336 Q34600820-47D0384C-34C8-4607-89D6-CCB1E5BF0304 Q34768188-1706FD7C-CA7C-4651-97E1-581AB8DCB0AC Q34979619-C1180C53-ABA3-430A-B5E4-1705CFF9F1F2 Q35007847-7B475D6F-065A-4ACA-BC59-E748E9273560 Q35182733-1A7AA748-CFD5-4246-A1CF-6B1563EC4B0B Q35213818-241CC3D7-03AD-4BE7-9229-8A23F1F25E99 Q35422678-154BBCD3-A88E-41E3-9AA5-34D00A3E762A Q35589934-18187D82-1111-41BB-8E6E-B079CAF23505 Q35603241-23020F36-563C-47EF-8DDC-5C6169A96B74 Q35654025-6083E138-867A-4430-9525-5E9384B445B5 Q35722755-138C3D13-78D1-4465-8A1B-DD14BA78FB23 Q35726466-AD60DFA8-DAD3-4942-8C06-C691A0BAFDA4 Q36054671-27F83B57-5547-4A60-81AC-64A941E3F4F4 Q36070752-33FE804A-B1DF-435E-9D9A-9A8F1CFD4232 Q36076501-D241DD50-C03F-40A1-96E6-B2C4BADDDF5E Q36102183-1883C4DA-7C8B-43AA-95EB-861ECFA82305 Q36737833-2B8F8121-7145-40BD-942A-8EE54B9C226A Q36819400-2DB39410-23F1-452F-8DFA-502F15538AC6 Q36861620-34814A9B-61C5-4E47-989E-109CE43A2A39 Q37194115-5D1CE113-9E45-4558-9563-F74CC9E05681 Q37202733-556C696F-3B44-45A6-B546-D2C58ED80EC0 Q37291581-81CBCFB8-CE3F-490C-AB1A-CEFFD277F18D Q37350687-64C0270D-E71C-41FE-8F49-B452475E3469 Q37499253-98DD92DF-4EDC-4E19-9EEF-C243AA95A7A4 Q37521318-120E8CA6-FCDF-463B-8BC4-14D5E03874C2

P2860

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.

http://www.wikidata.org/entity/Q37677911

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The therapeutic potential of m ...... nternational MSCT Study Group.

@en

The therapeutic potential of m ...... nternational MSCT Study Group.

@nl

type

label

The therapeutic potential of m ...... nternational MSCT Study Group.

@en

The therapeutic potential of m ...... nternational MSCT Study Group.

@nl

prefLabel

The therapeutic potential of m ...... nternational MSCT Study Group.

@en

The therapeutic potential of m ...... nternational MSCT Study Group.

@nl

P1433

Q37677911-B64C015A-A007-4261-ADE9-BC6813440886

P1476

Q37677911-49F4FDDC-2FEB-42E4-9C22-FE4CC19AD46D

P2093

Q37677911-29F9FCEC-ED2D-4145-A2C7-3F9E6D1EDD9E

Q37677911-5DDABEE0-6BC4-422A-BC17-EDEB842C9996

Q37677911-7759A914-BB05-4151-AABA-DBC5DB613142

Q37677911-8CF76948-0BCA-4138-A7E2-65DD6DCE10E2

Q37677911-964075F7-A50B-4CF0-ACAA-A1FACDBBD2B9

Q37677911-9783FFAB-0D4A-4FA9-B1CB-8DEAE6AAA8F5

Q37677911-BF770D67-4C2E-465B-9F8C-EE25E565B742

Q37677911-D44C9D85-DFD0-44B4-AEBB-654B7D8E6195

P2860

Q37677911-03C50ED9-1139-4D4B-AED4-1772D675F00D

Q37677911-1275CEFC-8D51-4494-B08D-047C7E95FC72

Q37677911-230A7A1A-173E-4918-AC09-48DC60ABB3C0

Q37677911-28087223-709B-4822-A205-BB1C119EF267

Q37677911-31B9FD37-75C6-4077-BC18-EED33C7A5E4E

Q37677911-34C15028-678A-4DE3-9EE7-942F25481021

Q37677911-3EBCE2C9-5814-4BE7-B710-0463364D9F0C

Q37677911-3F34674D-8C09-4EFC-95E1-DB277752D29C

Q37677911-51601798-F865-4EAF-8926-80656E676E7E

Q37677911-54EE85E8-5959-40A1-AABC-77C53E4560C5

P304

Q37677911-63C23F13-53D8-45F6-98BB-8E2B8724B84D

P31

Q37677911-AD8B06D1-85B1-4291-B466-7BBB22FD573A

P356

Q37677911-BC144A22-6B20-46D2-95EB-C12F02DE8C30

P433

Q37677911-77553D45-0114-42EE-89CB-9F5355441D8B

P478

Q37677911-2E6218C2-4261-452E-86E3-60AA0402844D

P50

Q37677911-0DD069D8-73D3-45F3-8C43-5CD284B3225F

Q37677911-3DB995DC-839C-4C2C-8C99-481E3067DD3E

Q37677911-61F6F59D-64C3-4E06-9C88-4CBCD818AF27

P577

Q37677911-1636178A-BECF-41CE-81A3-4014E3FC4705

P5875

Q37677911-F0A284CD-7092-4F5E-8E5B-5066B13C527F

P698

Q37677911-44157E82-5322-4CAE-9D0F-1137966BE2FD

P921

Q37677911-BF0C6005-4580-4B8B-A85E-6A80982EF33C

P356

1352458509359727

P1433

Multiple Sclerosis Journal

P1476

The therapeutic potential of m ...... nternational MSCT Study Group.

@en

P2093

Amit Bar-Or

http://www.w3.org/2001/XMLSchema#string

Dimitrios Karussis

http://www.w3.org/2001/XMLSchema#string

Harold L Atkins

http://www.w3.org/2001/XMLSchema#string

Katarina Le Blanc

http://www.w3.org/2001/XMLSchema#string

MSCT Study Group

http://www.w3.org/2001/XMLSchema#string

Mark S Freedman

http://www.w3.org/2001/XMLSchema#string

Neil Scolding

http://www.w3.org/2001/XMLSchema#string

Shimon Slavin

http://www.w3.org/2001/XMLSchema#string

P2860

Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice.

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

Mesenchymal stem cells in health and disease

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis.

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.

Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.

Autologous mesenchymal bone marrow stem cells: practical considerations.

P304

503-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458509359727

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Uccelli

Francesco Frassoni

Hillard M Lazarus

P577

2010-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41088122

http://www.w3.org/2001/XMLSchema#string

P698

20086020

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis